Dr. Knight is investigating the use of biocompatible nanoparticles as in vivo diagnostic imaging agents. The nanoparticles are targeted to molecular markers of disease and are detectable by imaging methods such as magnetic resonance imaging. It is hoped that disease-specific nanoparticles can be used to carry therapeutic agents as well as being used to provide initial diagnosis and monitoring of the progress of therapy. This work is an outgrowth of Dr. Knight’s work on physiologic imaging using radiotracers.
For more information, please visit Dr. Knight’s website.
PA Department of Community and Economic Development
“Technology Investment Office looks to NTI as a valued partner in harnessing the technology based economic development opportunities within PA’s nanotechnology community.”
—C. Alan Walker
Secretary, PA Department of Community
and Economic Development